NVIDIA (NASDAQ: NVDA) has long been the poster child of the artificial intelligence revolution. The company dominates GPU chipmaking, which powers cloud computing and generative AI models. However, its latest regulatory filing shows the company is quietly extending its reach far beyond hardware sales.
According to NVIDIA’s second-quarter 13F filing with the SEC, the chipmaker significantly increased its position in CoreWeave (CRWV), a fast-rising cloud infrastructure company specializing in GPU-powered AI workloads. As a result, in pre-market trading, NVIDIA shares have already risen 0.18% to $182.335.
NVIDIA owned roughly 24.3 million shares of CoreWeave as of June 30, up from 17.9 million at the time of CoreWeave’s IPO earlier this year. This stake is worth about $4.33 billion, making it the single largest equity holding of NVIDIA stock. Hence, it represents over 91% of the company’s investment portfolio.
CoreWeave has become one of the most closely watched AI stocks. The company offers tailor-made cloud solutions for machine learning and generative AI. For NVIDIA, the increased investment strengthens a strategic customer relationship and also ensures direct exposure to the growth of GPU-accelerated cloud services.
Beyond CoreWeave, NVIDIA’s portfolio includes smaller positions in Arm Holdings (ARM), Applied Digital (APLD), Nebius (NBIS), and Recursion Pharmaceuticals (RXRX). While these stakes are modest compared to CoreWeave, they highlight NVIDIA’s broader strategy to build an AI ecosystem spanning semiconductors, high-performance computing, and AI-driven drug discovery.
NVIDIA shares have already surged this year on AI optimism, and the company’s expanding equity bets reinforce its conviction in long-term AI infrastructure growth. By backing partners like CoreWeave, the global chipmaker isn’t just selling chips; it is actively shaping the future demand cycle. For investors, this signals continued upside potential but also exposure to the volatility of early-stage AI firms.
Also Read: NVIDIA Stock Slips 0.86% to $181.13 Despite Wells Fargo’s 20% Upside Prediction